Protagonist Therapeutics
PTGX
#3742
Rank
A$4.17 B
Marketcap
$70.09
Share price
-2.90%
Change (1 day)
187.83%
Change (1 year)

P/S ratio for Protagonist Therapeutics (PTGX)

P/S ratio as of November 2024 (TTM): 8.63

According to Protagonist Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.09. At the end of 2024 the company had a P/S ratio of 6.37.

P/S ratio history for Protagonist Therapeutics from 2016 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.37-71.11%
202322.09.16%
202220.2-66.16%
202159.796.96%
202030.3-96.35%
201983116361.66%
20185.05-76.83%
201721.8
2016N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA